Alpinia Biopharma Reema Private Limited, a active private limited company, was established on 20 October 2016 in Delhi, Delhi, India. Engaging in industrial chemicals within the trade sector, it holds CIN: U74110DL2016PTC307373. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹6.50 Cr and a paid-up capital of ₹2.55 Cr.
Formerly known as Alpinia Agri Tech Private Limited. It upholds a compliant status. Its leadership includes Anup Kumar Agarwal (Director), Bhalchandra Madhav Karandikar (Director), Anil Agrawal (Director). Past directors included Bhalchandra Madhav Karandikar, Narayan Madhav Karandikar, Ajay Kumar. Its latest AGM occurred on 17 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 29, Dheeraj Block South Ganesh Nagar, Delhi, Delhi, 110092.
U74110DL2016PTC307373
307373
20 October 2016
₹6.50 Cr
₹2.55 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Alpinia Biopharma Reema Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anup Kumar Agarwal | Director | 15 Sep 2023 | Current |
| Bhalchandra Madhav Karandikar | Director | 22 Aug 2018 | Current |
| Anil Agrawal | Director | 20 Oct 2016 | Current |
| Aditi Narayan Karandikar | Director | 23 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Sep 2018 | Past |
| Pramod Abcsdd | Director | 27 Apr 2021 | Past |
| Pramod Abcsdd | Director | 07 Nov 2017 | Past |
| Pramod Abcsdd | Additional Director | 23 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alpinia Biopharma Reema Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 186.95% increase. The company also saw a substantial fall in profitability, with a 212.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 37.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Alpinia Biopharma Reema had a promoter holding of 30.54% and a public holding of 69.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Alpinia Biopharma Reema, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Alpinia Biopharma Reema, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alpinia Biopharma Reema's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Alpinia Biopharma Reema Private Limited last Annual general meeting of members was held on 17 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Alpinia Biopharma Reema Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Anup Kumar Agarwal was appointed as a Director was appointed as a Director on 15 Sep 2023 & has been associated with this company since 2 years 3 months . was recorded as a recent event.
Aditi Narayan Karandikar was appointed as a Director was appointed as a Director on 23 Aug 2021 & has been associated with this company since 4 years 4 months . was recorded as a recent event.
Progress on Bhalchandra Madhav Karandikar was appointed as a Director was appointed as a Director on 22 Aug 2018 & has been associated with this company since 7 years 4 months . was documented.
The activity Anil Agrawal was appointed as a Director was appointed as a Director on 20 Oct 2016 & has been associated with this company since 9 years 2 months . was completed.
The CIN of Alpinia Biopharma Reema Private Limited is U74110DL2016PTC307373.
Alpinia Biopharma Reema Private Limited is headquartered at Plot No. 29, Dheeraj Block South Ganesh Nagar, Delhi, Delhi, 110092.
Alpinia Biopharma Reema Private Limited was incorporated on 20 October 2016.
The current directors of Alpinia Biopharma Reema Private Limited are
The primary industry of Alpinia Biopharma Reema Private Limited is Trade.
Alpinia Biopharma Reema Private Limited is unlisted.
The authorized capital of Alpinia Biopharma Reema Private Limited is ₹6.50 Cr, and the paid-up capital is ₹2.55 Cr.
The compliance status of Alpinia Biopharma Reema Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX